| Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer (NCT04642664) | Peking Union Medical College Hospital | 2018-12-01 |
| A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors (NCT03734926) | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 2018-11-13 |
| A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma (NCT03693807) | Memorial Sloan Kettering Cancer Center | 2018-10-18 |
| A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors (NCT03665285) | NextCure, Inc. | 2018-10-01 |
| Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma (NCT03603834) | Khon Kaen University | 2018-09-19 |
| A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) (NCT03207347) | University of Florida | 2018-08-13 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488) | Xencor, Inc. | 2018-07-10 |
| Personal Resilience Empowerment Program Study (NCT03644173) | Hackensack Meridian Health | 2018-05-30 |
| Precise Treatment System of Biliary Malignancies Based on Special Disease Database (NCT03499782) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2018-05-25 |
| Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients (NCT03473574) | AIO-Studien-gGmbH | 2018-05-02 |
| Clinical Trial of Autologous Tcm Immunotherapy in ICC (NCT03820310) | Newish Technology (Beijing) Co., Ltd. | 2018-05-01 |
| The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer (NCT03637569) | Samsung Medical Center | 2018-04-01 |
| A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma (NCT03377179) | RedHill Biopharma Limited | 2018-03-07 |
| SHR-1210 in Combination With GEMOX in Patients With Advanced BTC (NCT03486678) | The First Affiliated Hospital with Nanjing Medical University | 2018-02-10 |
| MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers (NCT06258824) | Imperial College London | 2018-01-01 |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry (NCT03452774) | Massive Bio, Inc. | 2018-01-01 |
| Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer (NCT04656249) | Peking Union Medical College Hospital | 2018-01-01 |
| Study on the Quality of Life (QoL) After Liver Surgery (NCT05464706) | Humanitas Clinical and Research Center | 2018-01-01 |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies (NCT03329950) | Celldex Therapeutics | 2017-12-01 |
| A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma (NCT03250273) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-11-06 |
| TAS-102 in Treating Advanced Biliary Tract Cancers (NCT03278106) | Mayo Clinic | 2017-10-20 |
| Molecular Epidemiology of Biliary Tree Cancers (NCT05179486) | M.D. Anderson Cancer Center | 2017-09-25 |
| A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors (NCT03172832) | Medical University of South Carolina | 2017-08-20 |
| A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms (NCT03219268) | MacroGenics | 2017-08-18 |
| Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures (NCT03211169) | Stanford University | 2017-07-29 |
| Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer (NCT03943043) | Istituto Clinico Humanitas | 2017-07-21 |
| Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic . (NCT03140007) | Asian Institute of Gastroenterology, India | 2017-06-15 |
| Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) (NCT03111732) | National Cancer Institute (NCI) | 2017-06-14 |
| A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy (NCT03338062) | Indiana University | 2017-06-13 |
| RFA for Malignant Biliary Obstruction (NCT03166436) | Institute for Clinical and Experimental Medicine | 2017-06-08 |
| An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies (NCT03144661) | Incyte Corporation | 2017-05-25 |
| Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma (NCT03079427) | Asan Medical Center | 2017-05-15 |
| ncRNAs in Exosomes of Cholangiocarcinoma (NCT03102268) | The Second Hospital of Nanjing Medical University | 2017-05-01 |
| A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors (NCT02990481) | Toray Industries, Inc | 2017-03-06 |
| Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma (NCT03042182) | Immunitor LLC | 2017-02-20 |
| Observational Study on Patients With Hepatobiliary Tumors (NCT04637048) | Gang Chen, MD | 2017-02-16 |
| A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer (NCT03027284) | Eli Lilly and Company | 2017-02-03 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| FGF19 in Obstructive Cholestasis: "Unveil the Signal" (NCT05718349) | Nicole Hildebrand | 2017-01-01 |
| Biobank for Cholestatic Liver Diseases. (NCT03445585) | Mayo Clinic | 2017-01-01 |
| Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal (NCT06888401) | Kathmandu University School of Medical Sciences | 2017-01-01 |
| A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors (NCT02784795) | Eli Lilly and Company | 2016-11-04 |
| Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors (NCT02607826) | University Hospital Tuebingen | 2016-11-01 |
| Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy (NCT01642875) | Medical University of Warsaw | 2016-11-01 |
| Enteral Nutrition After Pancreaticoduodenectomy (NCT03150615) | Nanjing Medical University | 2016-09-01 |
| A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) (NCT02821754) | National Cancer Institute (NCI) | 2016-07-05 |
| Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma (NCT02631590) | H. Lee Moffitt Cancer Center and Research Institute | 2016-07-05 |
| Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle (NCT02872831) | Thomas Jefferson University | 2016-07-01 |
| Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples (NCT02762721) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2016-06-06 |
| Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma (NCT02456714) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-05-31 |
| WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer (NCT02757859) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2016-04-27 |
| Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma (NCT02730611) | Assistance Publique - Hôpitaux de Paris | 2016-03-01 |
| Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function (NCT02626312) | M.D. Anderson Cancer Center | 2016-02-15 |
| Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction (NCT02649712) | Xuzhou Central Hospital | 2016-01-20 |
| Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors (NCT02665494) | Fondazione del Piemonte per l'Oncologia | 2016-01-01 |
| A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction (NCT02659852) | Yonsei University | 2016-01-01 |
| DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture (NCT04568512) | Mahidol University | 2016-01-01 |
| Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery (NCT02520141) | M.D. Anderson Cancer Center | 2015-12-29 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies (NCT02638909) | Criterium, Inc. | 2015-12-01 |
| Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma (NCT02592538) | First People's Hospital of Hangzhou | 2015-12-01 |
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (NCT02568267) | Hoffmann-La Roche | 2015-11-19 |
| ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy (NCT02609958) | ASLAN Pharmaceuticals | 2015-11-16 |
| Metformin And Chloroquine in IDH1/2-mutated Solid Tumors (NCT02496741) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-11-01 |
| RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy (NCT02452970) | EpicentRx, Inc. | 2015-07-16 |
| Laparotomy, Laparoscopy, da Vinci System (NCT07034495) | National Chung Hsing University | 2015-07-01 |
| In Vitro Models of Liver and Pancreatic Cancer (NCT02436564) | Cambridge University Hospitals NHS Foundation Trust | 2015-07-01 |
| Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma (NCT02548195) | Shanghai Zhongshan Hospital | 2015-07-01 |
| Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder (NCT02375880) | Leap Therapeutics, Inc. | 2015-06-01 |
| A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck (NCT02479178) | BIND Therapeutics | 2015-06-01 |
| Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma (NCT02773485) | Tata Memorial Hospital | 2015-05-01 |
| Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma (NCT02428855) | Massachusetts General Hospital | 2015-04-01 |
| Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome (NCT04792463) | Mohamed Abdel-Rahman | 2015-03-03 |
| Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) (NCT02393248) | Incyte Corporation | 2015-02-27 |
| A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer (NCT02232633) | Sumitomo Pharma America, Inc. | 2015-02-01 |
| Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer (NCT05184400) | Herlev and Gentofte Hospital | 2015-01-01 |
| Radiofrequency Ablation for Biliopancreatic Malignancy (NCT02468076) | Universitaire Ziekenhuizen KU Leuven | 2014-11-01 |
| A Study of TAS-120 in Patients With Advanced Solid Tumors (NCT02052778) | Taiho Oncology, Inc. | 2014-07-21 |
| Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery (NCT02174575) | Tokyo Medical and Dental University | 2014-07-01 |
| Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma (NCT02128282) | Senhwa Biosciences, Inc. | 2014-06-01 |
| Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer (NCT02106871) | The University of Texas Medical Branch, Galveston | 2014-04-01 |
| Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers (NCT03003065) | Chinese University of Hong Kong | 2014-03-28 |
| Regorafenib Versus Placebo to Treat Cholangiocarcinoma (NCT02162914) | Erasme University Hospital | 2014-03-14 |
| Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma (NCT02232932) | Assistance Publique - Hôpitaux de Paris | 2014-03-01 |
| Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation (NCT02073994) | Institut de Recherches Internationales Servier | 2014-03-01 |
| Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers (NCT01926236) | The Christie NHS Foundation Trust | 2014-02-01 |
| Liver and Biliary Tumor Tissue Registry (NCT02917759) | Mayo Clinic | 2014-02-01 |
| Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. (NCT02012231) | Fore Biotherapeutics | 2014-02-01 |
| Endoscopic Biliary RFA of Malignant Bile Duct Obstruction (NCT02582541) | The Second Hospital of Nanjing Medical University | 2014-02-01 |
| Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm (NCT02528526) | University of Zurich | 2014-02-01 |
| Diagnosis of Bile Duct Strictures (NCT02000999) | Washington University School of Medicine | 2013-11-01 |
| Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma (NCT01912053) | Center Eugene Marquis | 2013-09-01 |
| S-1 in Combination With Abraxane in Treating Cholangiocarcinoma (NCT01963325) | Yuhong Li | 2013-08-01 |
| Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer (NCT01915225) | National Cancer Institute (NCI) | 2013-07-21 |
| International Registry on Cholangiocarcinoma Treatment (NCT01920503) | International Group of Endovascular Oncology | 2013-07-01 |
| Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer (NCT01855724) | Hellenic Cooperative Oncology Group | 2013-06-28 |
| Safety and Efficiency of Photodynamic Therapy for Blie Duct Carcinoma (NCT01859169) | li xiong | 2013-06-01 |
| Endobiliary RFA for Unresectable Malignant Biliary Strictures (NCT01844245) | Bing Hu | 2013-05-01 |
| Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent (NCT01875549) | Kwang Hyuck Lee | 2013-05-01 |
| A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas (NCT01900158) | PCI Biotech AS | 2013-05-01 |